Purine antagonists for chronic lymphocytic leukemia: Results of a comprehensive meta-analysis

Steurer, M, Pall, G, Richards, S, Schwarzer, G, Bohlius, J, Greil, R ANN ONCOL. 2005, 16: 203-204.

Chemotherapie im Alter

Greil, R, Faber, V, In: Likar, R, Bernatzky, G, Pipam, W, Janig, H, Sadjak, A, editors(s). Lebensqualität im Alter. Springer, p. 57-264. (ISBN: 978-3-211-21197-7)

ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients

Fey, MF, Greil, R, Jost, LM Ann Oncol. 2005,16 Suppl 1:i48-9.

Long-term results of dose density therapy in patients with aggressive lymphoma.

Fridrik MA, Hausmaninger H, Linkesch W, Greil R, Krieger O, Baldinger C, Klocker J, Pont J, Oberaigner W. Ann Hematol. 2005 Apr,84(4):217-22. Epub 2004 Nov 6.

Polyacetylenes from the Apiaceae vegetables carrot, celery fennel parsley and parsnip and their cytotoxic activities.

Zidorn C, Jöhrer K, Ganzera M, Schubert B, Sigmund EM, Mader J, Greil R, Ellmerer EP, Stuppner H. J Agric Food Chem. 2005 Apr 6,53(7):2518-23.

Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma.

Jöhrer K, Zelle-Rieser C, Perathoner A, Moser P, Hager M, Ramoner R, Gander H, Höltl L, Bartsch G, Greil R, Thurnher M. Clin Cancer Res. 2005 Apr 1,11(7):2459-65.

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of multiple myeloma.

Harrouseau JL, Greil R, Kloke O Ann Oncol. 2005,16 Suppl 1:i48-9. No abstract available.

ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of acute myeloblastic leukemia (AML) in adult patients.

Fey MF, Greil R, Jost LM Ann Oncol. 2005,16 Suppl 1:i48-9. No abstract available.

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of chronic lymphocytic leukemia.

Hallek M, Stahel RA, Greil R Ann Oncol. 2005,16 Suppl 1:i50-1. No abstract available.

ESMO recommendations for the application of hematopoietic growth factors.

Greil R, Jost LM Ann Oncol. 2005,16 Suppl 1:i80-2. No abstract available.